NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054549

Registered date:10/06/2024

Utility of SalivaChecker in Screening for Pancreatic Cancer

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedPancreatic Cancer
Date of first enrollment2024/06/10
Target sample size20
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeRisk assessment of determined by Saliva Checker. The results are graded into four levels: A (very low risk), B (low risk), C (high risk), and D (very high risk) for lung, breast, colon, stomach, pancreatic, and oral cancer, respectively.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1. Patients with severe xerostomia. 2. Pregnant or lactating patients. 3. Patients with severe cognitive impairment. 4. Other patients deemed inappropriate research subjects by the investigator or others. 5. Patients included in a previous study (Preliminary Study on the Usefulness of Saliva Checker for Cancer Risk Assessment (Saliva Checker), Approval No. 230821039).

Related Information

Contact

public contact
Name Sakiko Soutome
Address 1-7-1, Sakamoto, Nagasaki Japan 852-8588
Telephone 0958197663
E-mail sakiko@nagasaki-u.ac.jp
Affiliation Nagasaki University Preventive Dentistry
scientific contact
Name Sakiko Soutome
Address 1-7-1, Sakamoto, Nagasaki Japan
Telephone 095-819-7663
E-mail sakiko@nagasaki-u.ac.jp
Affiliation Nagasaki University Preventive Dentistry